Cargando…

Efficacy and safety of tamsulosin hydrochloride 0.2 mg and combination of tamsulosin hydrochloride 0.2 mg plus solifenacin succinate 5 mg after transurethral resection of the prostate: a prospective, randomized controlled trial

OBJECTIVE: The objective of this study was to evaluate the safety and efficacy of tamsulosin hydrochloride 0.2 mg (TAM) and its combination with solifenacin succinate 5 mg (SOL) after transurethral resection of the prostate (TURP). PATIENTS AND METHODS: The patients were randomized into three groups...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shin, Yu Seob, Zhang, Li Tao, You, Jae Hyung, Choi, In Sung, Zhao, Chen, Park, Jong Kwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034924/ https://www.ncbi.nlm.nih.gov/pubmed/27698559 http://dx.doi.org/10.2147/CIA.S115042

Ejemplares similares

Evidence Is Enough?: A Systematic Review and Network Meta-Analysis of the Efficacy of Tamsulosin 0.2 mg and Tamsulosin 0.4 mg as an Initial Therapeutic Dose in Asian Benign Prostatic Hyperplasia Patients
por: Kim, Su Jin, et al.
Publicado: (2017)

Letter to the Editor: Commentary on “Evidence Is Enough?: A Systematic Review and Network Meta-Analysis of the Efficacy of Tamsulosin 0.2 mg and Tamsulosin 0.4 mg as an Initial Therapeutic Dose in Asian Benign Prostatic Hyperplasia Patients”
por: Tae, Bum Sik, et al.
Publicado: (2017)

The Authors Reply: Reply on “Evidence Is Enough?: A Systematic Review and Network Meta-Analysis of the Efficacy of Tamsulosin 0.2 mg and Tamsulosin 0.4 mg as an Initial Therapeutic Dose in Asian Benign Prostatic Hyperplasia Patients”
por: Kim, Su Jin, et al.
Publicado: (2017)

Evaluation of the pharmacokinetics and food effects of a novel formulation tamsulosin 0.4 mg capsule compared with a 0.2 mg capsule in healthy male volunteers
por: Ban, Mu Seong, et al.
Publicado: (2020)

An open-label, prospective interventional study of the tolerability and efficacy of 0.4 mg oral tamsulosin oral controlled absorption system in men with lower urinary tract symptoms associated with benign prostatic hyperplasia who are unsatisfied with treatment with 0.2 mg tamsulosin
por: Yang, Pei-Shan, et al.
Publicado: (2018)

A Prospective, Multicenter, Open-Label Study of Dose Escalation Therapy in Male Patients With Nocturia Refractory to 0.2-mg Tamsulosin Monotherapy
por: Yu, Ho Song, et al.
Publicado: (2019)

Is Tamsulosin 0.2 mg Effective and Safe as a First-Line Treatment Compared with Other Alpha Blockers?: A Meta-Analysis and a Moderator Focused Study
por: Shim, Sung Ryul, et al.
Publicado: (2016)

Efficacy and Tolerability of Tamsulosin 0.4 mg in Patients with Symptomatic Benign Prostatic Hyperplasia
por: Chung, Jae-Wook, et al.
Publicado: (2011)

Spectrophotometric estimation of tamsulosin hydrochloride by acid-dye method
por: Shrivastava, Alankar, et al.
Publicado: (2011)

Stabilization by Configurational Entropy of the Cu(II) Active Site during CO Oxidation on Mg(0.2)Co(0.2)Ni(0.2)Cu(0.2)Zn(0.2)O
por: Fracchia, Martina, et al.
Publicado: (2020)

Is configurational entropy the main stabilizing term in rock-salt Mg(0.2)Co(0.2)Ni(0.2)Cu(0.2)Zn(0.2)O high entropy oxide?
por: Fracchia, Martina, et al.
Publicado: (2022)

Beneficial Effect of Increasing the Dose of Tamsulosin to 0.4 mg in Japanese Patients with Benign Prostatic Hyperplasia
por: Hirose, Yasuhiko, et al.
Publicado: (2011)

Efficacy of 0.4 mg tamsulosin monotherapy in patients with moderate-to-severe lower urinary tract symptoms
por: Kang, Tae Wook, et al.
Publicado: (2021)

High-Entropy Sn(0.8)(Co(0.2)Mg(0.2)Mn(0.2)Ni(0.2)Zn(0.2))(2.2)O(4) Conversion-Alloying Anode Material for Li-Ion Cells: Altered Lithium Storage Mechanism, Activation of Mg, and Origins of the Improved Cycling Stability
por: Moździerz, Maciej, et al.
Publicado: (2022)

Development by Mechanochemistry of La(0.8)Sr(0.2)Ga(0.8)Mg(0.2)O(2.8) Electrolyte for SOFCs
por: Garcia-Garcia, Francisco J., et al.
Publicado: (2020)

Tunable pseudocapacitive contribution by dimension control in nanocrystalline-constructed (Mg(0.2)Co(0.2)Ni(0.2)Cu(0.2)Zn(0.2))O solid solutions to achieve superior lithium-storage properties
por: Chen, Hong, et al.
Publicado: (2019)

RP – HPLC method for the estimation of Tamsulosin Hydrochloride in Tablet Dosage Form
por: Kumari, Richa, et al.
Publicado: (2010)

Effect of Improvement in Lower Urinary Tract Symptoms on Sexual Function in Men: Tamsulosin Monotherapy vs. Combination Therapy of Tamsulosin and Solifenacin
por: Ko, Kyungtae, et al.
Publicado: (2014)

A new spinel high-entropy oxide (Mg(0.2)Ti(0.2)Zn(0.2)Cu(0.2)Fe(0.2))(3)O(4) with fast reaction kinetics and excellent stability as an anode material for lithium ion batteries
por: Chen, Hong, et al.
Publicado: (2020)

Tadalafil 5 mg Alone or in Combination with Tamsulosin 0.4 mg for the Management of Men with Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Prospective Observational Trial
por: Sebastianelli, Arcangelo, et al.
Publicado: (2019)

Treatment persistence with a fixed-dose combination of tadalafil (5 mg) and tamsulosin (0.4 mg) and reasons for early discontinuation in patients with benign prostatic hyperplasia and erectile dysfunction
por: Ahn, Sun Tae, et al.
Publicado: (2020)

Effect of Microstructure Refinement on the Corrosion Behavior of the Bioresorbable Mg-1Zn-0.2Ca and Mg-1Ca Alloys
por: Kulyasova, Olga B., et al.
Publicado: (2022)

Tamsulosin and Solifenacin in the Treatment of Benign Prostatic Hyperplasia in combination with overactive bladder
por: Wang, Hui, et al.
Publicado: (2017)

AB151. Clinical study on the treatment of lifelong premature ejaculation with paroxetine hydrochloride and tamsulosin
por: Zhang, Chao, et al.
Publicado: (2014)

AB212. Clinical study on the treatment of lifelong premature ejaculation with Paroxetine hydrochloride and tamsulosin
por: Li, Yan-Feng, et al.
Publicado: (2016)

A comparison of the efficacy of naftopidil and tamsulosin hydrochloride in medical treatment of benign prostatic enlargement
por: Perumal, Chenthil, et al.
Publicado: (2015)

The effectiveness of tamsulosin hydrochloride with terazosin combination therapy for chronic prostatitis Type-III b
por: Duan, Bin, et al.
Publicado: (2022)

Modulating the Energy Band Structure of the Mg-Doped Sr(0.5)Pr(0.5)Fe(0.2)Mg(0.2)Ti(0.6)O(3−δ) Electrolyte with Boosted Ionic Conductivity and Electrochemical Performance for Solid Oxide Fuel Cells
por: Rauf, Sajid, et al.
Publicado: (2022)

Effects of Tamsulosin, Solifenacin, and Combination Therapy for the Treatment of Ureteral Stent Related Discomforts
por: Lim, Kyoung Taek, et al.
Publicado: (2011)

Randomized Double-Blind Controlled Trial Comparing 0.2 mg, 0.1 mg, and No Intrathecal Morphine Combined With Periarticular Injection for Unilateral Total Knee Arthroplasty
por: Pathonsamit, Chompunoot, et al.
Publicado: (2020)

Constitutive Equation and Hot Compression Deformation Behavior of Homogenized Al–7.5Zn–1.5Mg–0.2Cu–0.2Zr Alloy
por: He, Jianliang, et al.
Publicado: (2017)

Efficacy of cyclic and extended regimens of ethinylestradiol 0.02 mg ‐levonorgestrel 0.09 mg for dysmenorrhea: A placebo‐controlled, double‐blind, randomized trial
por: Harada, Tasuku, et al.
Publicado: (2021)

Effect of the Ca(2)Mg(6)Zn(3) Phase on the Corrosion Behavior of Biodegradable Mg-4.0Zn-0.2Mn-xCa Alloys in Hank’s Solution
por: Fu, Junjian, et al.
Publicado: (2022)

Comparison of Periochip (chlorhexidine gluconate 2.5 mg) and Arestin (Minocycline hydrochloride 1 mg) in the management of chronic periodontitis
por: Jhinger, Navjot, et al.
Publicado: (2015)

On the structural and electrical properties of MgFe(2)O(4), MgMn(0.2)Fe(1.8)O(4), and Mn(3)O(4)
por: Farshidfar, F., et al.
Publicado: (2023)

Rb/Cs-Modified P2 Na(0.7)Mn(0.8)Mg(0.2)O(2): Application in Sodium-Ion Batteries
por: Sehrawat, Divya, et al.
Publicado: (2019)

Investigation on the Selenization Treatment of Kesterite Cu(2)Mg(0.2)Zn(0.8)Sn(S,Se)(4) Films for Solar Cell
por: Jiang, Dongyue, et al.
Publicado: (2019)

Zn–0.8Mg–0.2Sr (wt.%) Absorbable Screws—An In-Vivo Biocompatibility and Degradation Pilot Study on a Rabbit Model
por: Klíma, Karel, et al.
Publicado: (2021)

A detailed mechanism of degradation behaviour of biodegradable as-ECAPed Zn-0.8Mg-0.2Sr with emphasis on localized corrosion attack
por: Pinc, Jan, et al.
Publicado: (2023)

Comparative analysis of safety and efficacy of Alcaftadine 0.25%, Olopatadine hydrochloride 0.2% and Bepotastine besilate 1.5% in allergic conjunctivitis
por: Ayyappanavar, Shruti, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ep3rqlbdvqj69dj09f5j7bsic3